DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/wtpls5/global_fibrin) has announced the addition of the "Global Fibrin Sealants Market 2016-2020" report to their offering.
The global fibrin sealants market is expected to grow at a CAGR of 9.14% during the period 2016-2020.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Fibrin sealant, a two-component substance consisting of thrombin and fibrinogen, is used as a hemostatic or adhesive in various surgical solutions. In clinical practice, a fibrin sealant consists of a concentrated solution of fibrinogen and Factor XIII, which combine with a solution of calcium and thrombin to form a coagulum that stimulates clotting.
The approval for the use of fibrin sealants in extended applications has helped many vendors develop innovative fibrin sealants, which have two or more applications. For instance, a fibrin sealant can be used in tissue sealing of a particular organ and in general tropical surgery.
- Baxter International
- CSL Behring
- Johnson & Johnson (Ethicon)
- Asahi Kasei Medical
- C.R. Bard (Bard Medical Davol)
- Hualan Biological
- Harvest Technologies
- Pharming Group
- Sea Run
- Shanghai RAAS
- STB Lifesaving Technologies
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Product pipeline analysis
PART 06: Market landscape
PART 07: Geographical segmentation
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
For more information visit http://www.researchandmarkets.com/research/wtpls5/global_fibrin